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In a 'Small Iowa Town 
I N A SMALL Iowa town more than 50 years ago, I was with an old Irish priest 
who was unable to complete a requiem mass 
,that, for him, meant everything. He wept 
instead, and explained to those gathered that 
his heart was too full to go on. Father O'Toole 
taught me then to guard against moments like 
now when feelings can betray us by destroying 
the power of speech. 
Thus, I will be impersonal, if that is' possible 
on an occasion like this. I can only say that no 
day will go by in the rest of my life when I will 
not think of, and be strengthened by, what has 
happened this week. It is the kind of debt that 
few people incur and none can pay. Thank you 
for coming here. 
Transplantation is the common bond that 
brought us together in the first place and has 
kept us together since. How new this field 
reall y is, and how unexpected. In 1961, the 
Nobel Laureate, Burnet, wrote in the New 
England Journal of Medicine that "much 
thought has been given to ways by which 
tissues or organs not genetically and antigeni-
cally identical with the patient might be made 
to survive and function in the alien environ-
ment. On the whole, the present outlook is 
.. \ Th' highly unfavorable to success. . . . IS pes-
simistic view was published only a year before 
the avalanche of successful clinical renal 
transplantations in 1962 and 1963 that 
extended such procedures beyond the occa-
sional identical and fraternal twin cases of the 
mid- and late 1950s. Developments since then 
in transplantation have revolutionized the 
practice of medicine. It is the effect of these 
burgeoning successes upon both society and 
medicine that I want to discuss today. 
WHY MEDICINE HAS CHANGED AND HOW 
Why has there been such an impact on 
medicine? Up to now, transplantation tech-
niques have been expensive. Relatively few 
lives, probably less than 100,000, have been 
actually saved. 
A Change in Philosophy 
The reason is that transplantation has made 
possible a fundamental philosophic departure 
in the way that health care is delivered. Until 
50 or 60 years ago, practitioners of medicine 
observed and presided over lethal diseases, 
powerless to provide much more than a 
priestly function. This began to change with 
increasingly specific drugs such as antibiotics, 
but for most organ-specific chronic disorders, 
a rear guard strategy was all that could be 
offered. Patients with failing kidneys, livers, 
or hearts could be treated' with diet, medi-
cines, or with operations that often were illogi-
cally designed. Suddenly, with the advent of 
transplantation, it became possible for the 
first time in human history to provide exactly 
what was needed, a completely new organ. 
Those who in small groups .sat around small 
tables in the early 1960s and discussed renal 
transplantation understood perfectly how 
high the stakes were or could be. 
But immunosuppression was too poor to 
apply this thrilling concept widely until the 
1980s. Then, with the introduction of cyclo-
sporine, it became obvious that a great escape 
hatch had not only been formed but that all 
future judgement in the care of organ-specific 
diseases would have to be in the new perspec-
tive of possible eventual organ replacement. 
Nowhere was this more clear than in liver 
disease, in which mutilating operations in the 
portal hilum such as portacaval shunts were 
virtually abandoned overnight since they jeo-
pardized eventual candidacy for liver trans-
plantation. Similar examples with renal and 
cardiac disease easily could be cited. 
To many physicians, thoughts turned back 
to what might have been. How much more 
complete might the world have been if Mozart 
had been treated with renal transplantation 
instead of dying of glomerulonephritis at the 
age of 34. Or, closer to home, what might have 
become of that little girl so mourned by 
Father O'Toole 50 years ago in a small town 
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in Iowa. The people who could be most helped 
by t.ransplantation were those with the 
greatest potential, often at a young age, who 
had been doomed by failure of a single organ 
system but with all other organ systems intact. 
Now, tney could be saved. It was like a 
miracle. 
Administrative and Educational Changes 
In addition, transplantation has forced a 
change in the way that medicine has been 
taught and organized. The breadth and depth 
of expertise required to be at the State of the 
Art, much less progressive, in transplantation, 
have gone beyond the grasp of single individu-
als. Interdisciplinary teams have been formed 
within medical schools and hospitals that have 
cut across classical departmental and divi-
sionallines. These new alliances have changed 
the face not only of practice but of research 
and have had wide-ranging influence on the 
development of other special fields. 
Research Potential 
A special note should be made about the 
extraordinary influence of transplantation on 
both basic and clinical research. Modern 
immunology has been in partnership with, not 
sponsorship of, transplantation. Our under-
standing of autoimmune diseases and the 
appropriate treatment of these disorders owes 
much to observations after transplantation, an 
undertaking that first creates and then 
attempts to control the autoimmune disease 
known as rejection. 
Nowhere has the research potential of 
transplantation been more evident than with 
liver replacement. Although all liver trans-
plantations are therapeutic, every such opera-
tion also is a potential incisive experiment in 
basic physiology. With the treatment of some 
inborn errors of metabolism such as type I 
glycogen storage disease, cure of the disorder 
by provision of the missing enzyme with the 
new liver was highly predictable. In other 
disorders such as Wilson's disease, classical 
hemophilia, and hypercholesterolemia, more 
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was learned about the true nature of the 
original disease by the discriminating study of 
a single human liver recipient than by all of 
the prior investigations over many years put 
together. 
Finally, such a simple question as what are 
the necessary conditions for optimal revascu-
larization of a transplanted liver has led to a 
major breakthrough in an understanding of 
liver physiology and of the influence that the 
so-called hepatotrophic hormones such as 
insulin have upon liver structure, function, 
and the capacity for regeneration. This sub-
ject is being treated elsewhere in this sympo-
sium. 
Thus. transplantation became the Pan-
dora's box of 20th-century science. 
WHY AN IMPACT ON SOCIETY? 
When one man flew, as impractical as this 
was at first, the prospect of leaving the ground 
below and soaring like a bird was open to all 
men and women. The human condition rose to 
a higher level. Not to fly again was inconceiv-
able, even though it may have been against all 
instincts. 
So it was with transplantation, an even 
more unnatural event. As with flying, trans-
plantation violated some of society's deepest 
taboos. Why? The mores or religious codes 
that govern us usually have a real basis of 
bitter lessons long forgotten but with lingering 
shadows. One need go no further back than to 
the discovery of kuru, the disease in New 
Guinea caused by a slow-acting virus to real-
ize how a civilization can be wiped out by 
systematically exposing a human population 
to infected human blood and tissues. With 
kuru, the mode of spread was cannibalism. It 
may have been more than a Freudian slip in 
1964 when an editorial in the Annals of 
Internal Medicine, criticizing the ethics as 
well as the practicality of clinical renal trans-
plantation, began with the highlighted word 
"cannibalizing. ,,2 
It is obvious that there is no more intimate 
human contact than with transplantation in 
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which the objective is to transfer living tissue 
under'the most perfect possible conditions, 
The corollary is that diseases, including can-
cer, can be transplanted in the process. In the 
1960s pa~ients and health care personnel in 
transplant wards were infected in hepatitis 
epidemics worldwide, before serologic mark-
ers were discovered that permitted epidemo-
logic studies and prevention. Hardly a trans-
plant surgeon in that era escaped infection. 
My chief research technician. a woman 
named Phyllis Nagel, died from hepatitis and 
so did many others. Eventually, it was proved 
that a hepatitis reservoir existed in the trans-
plant wards and clinics, and measures could 
be taken to minimize the dangers. 
An array of other viruses have been indige- " 
nous in transplant centers. Most recently, 
acquired immunodeficiency syndrome 
(AIDS) carriers have been found in every 
major transplant program in which screening 
of the postoperative recipient population has 
been carried out systematically. Many of 
these patients already had been infected 
before transplantation in the course of their 
original illness by blood transfusions and other 
factors. A few obtained the AIDS virus from 
infected donors before donor testing was avail-
able. In almost half, the time and circum-
stances of infection never could be deter-
mined. The conclusion is clear, as it was with 
hepatitis that precautions are crucial to pre-
vent the transplant centers from being disease 
reservoirs from which other patients as well as 
health care personnel can be infected. 
Now that preoperative transplant candi-
date screening for AIDS is being carried out 
widely, patients are being discovered in 
increasing numbers who present with failure 
of a vital organ and who are found during 
evaluation to be asymptomatic AIDS virus 
carriers. To their great credit, workers in 
transplantation have not precluded organ 
replacement in these patients, thus avoiding a 
moral dilemma of forcing a candidate to take 
a test that could, if positive, deprive him or her 
of live-saving treatment. 
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Decisions about what does or does not pre-
clude candidacy for transplantation is not the 
sole responsibility of physicians. Society must 
playa role, and because of that I have brought 
the matter to your attention today. Society 
eventually pays the bills, and controls the 
resources, a subject to which I will return. 
Suffice it to say here that the real question is 
not why transplantation should impact on and 
be of interest to society, but rather how this 
impact has been felt. 
HOW SOCIETY HAS CHANGED 
The impact has been seen everywhere; in 
the law, in government, in philosophy, and in 
the perception of ethics. The leaders of all of 
the world's great religions have had to con-
sider the implications of transplantation in 
their beliefs. 
The new issues began to emerge 25 years 
ago. Before then, transplantation was not a 
practical therapeutic option. In 1962 and 
1963, using the drug combination of azathio-
prine and prednisone, apparently healthy 
recipients of kidneys began to emerge from 
clinics in increasing numbers. Some are here 
today, a quarter of a century later. 
The implications did not go unnoticed. In 
1965, a meeting was convened at the Ciba 
House in London to consider what the early 
successes in renal transplantation truly 
meant. Of the 28 participants, a few also are 
here today. The symposium proceedingsJ 
touched on all of the topics that still occupy 
'our thoughts including human experimenta-
tion, living donation, informed consent, brain 
death, and allocation of scarce resources. 
Then 39 years old, I came to that meeting sure 
of everything. I left it certain of nothing. 
To begin with, I had never previously ques-
tioned the propriety of living kidney donation, 
having been the principal proponent in the 
world of this practice. I left London a few days 
later with a brooding concern that promotion 
of living donation could be a subtle violation of 
human rights, even under the best of circum-
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stances, and that free choice and informed 
consent might actually be unattainable. 
I came to the meeting opposed to the con-
cept of heart-beating cadaveric donors. I left 
convinced of the legitimacy of brain death. 
My fear had been that the terminal care of 
gravely injured and helpless victims would be 
jeopardized by virtue of planned or actual 
organ removal. 
From the London discussions in 1965, it 
became obvious that acceptance of brain 
death could be expected to improve, not 
degrade, the quality of care for neurologically 
disabled patients. Until the 1960s, immediate 
assessments were made in emergency rooms 
about whether neurologically damaged pa-
tients could survive. Snap decisions were 
required whether to perform endotracheal 
intubation and whether to provide ventilatory 
support. With the acceptance of brain death, 
all patients could be so treated as the auto-
matic first step. The gravity of the brain 
injury could be analyzed later by the neurolo-
gists and neurosurgeons under optimal diag-
nostic conditions. An earlier opinion of Pope 
Pius XII was discussed in London that held 
that ventilators and other means of extraordi-
nary support could be discontinued if brain 
death was found to have occurred. Discontinu-
ance of extraordinary support for brain dead 
patients was thought legal by four lawyers and 
jurists. at the Ciba conference including Lord 
Kilbrandon, Chief High Justice of Scotland. 
Until this issue was settled, accusations of 
"murder" sometimes followed the detachment 
of ventilators. 
The concept of brain death was popularized 
in the United States 3 years later by the 
so-called Harvard ad hoc committee. Laws 
were quickly passed in the United States and 
in many countries that gave legal sanction t.o 
what society had already decided. Thus, the 
face of the law was changed by transplanta-
tion. Warren Burger, later to become Chief 
Justice of the United States Supreme Court, 
remarked at a subsequent and similar medical 
ethics conference in 1967, " ... it is not the 
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role and function of the law to keep pace with 
science ... the law does not make discoveries 
as you do; the law evolves and evolves slowly. 
It responds rather than anticipates. ,,4 By 
1968, the law had responded, and it has 
continued to do so since. 
Thinking back to that 1965 meeting, the 
thing that I remember best was concern for 
human rights and a determination that human 
experimentation should not blight this new 
field. Three of the 28 Ciba symposium partici-
pants had known degradation first hand in 
prison camps and concentration camps. Mem-
ories of atrocities, genocide, and war crimes 
trials were fresh. 
The Nuremberg code and the Helsinki 
declaration of 1964 were used as the frame 
work to judge what had already been done in 
transplantation and what might be considered 
next. The Helsinki declaration distinguished 
between non therapeutic research designed 
solely for the objective of acquiring informa-
tion as opposed to the use of unproven therapy 
in which the subjects who bore the risks were 
the same as those who stood to benefit. Trans-
plantation was a classical example of thera-
peutic investigation. The risks and benefits of 
so-called innovative procedures could be 
weighed without equivocation for the first 
recipients of kidneys, livers, hearts, and other 
organs. Although stones could be thrown, 
there were no solid hits. What was done in 
transplantation in those days was sometimes 
foolish,but it was never ignoble. 
In later times, there has been a tendency to 
construct formal and sometimes elaborate 
"human experiments" comparing different 
kinds of therapy. I once heard it seriously 
proposed that bonafide candidates for liver or 
heart transplantation should be randomized 
into those receiving therapy v untreated con-
trols. I described such suggestions as random-
ized trialomania. This was a fair criticism. 
However, trialomania can present with more 
subtle symptoms, such as insistence upon car-
rying on randomized trials before learning 
how to use new therapeutic tools. There is no 
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better way to discredit promising new devel-
opments. When cyclosporine was first used 
clinically, multiple, unanticipated manage-
ment problems were encountered, necessitat-
ing a large number of pilot cases. With this 
experience, effective management shemes 
were evolved, including combination therapy 
with other drugs, especially steroids. There 
was no justification during this time for a 
randomized trial, yet nearly continuous pres-
sure to conduct such a trial came fr~m many 
sources. 
Even worse than premature randomization 
is randomization after the fact. For a random-
ized clinical trial to be carried out ethically, 
the necessary starting point is a null hypothe-
sis of no treatment difference. A question that'. 
physicians must ask before assigning patients 
to a randomized trial is whether they would 
allow therapy to be decided by lot for them-
selves or their family members if they suffered 
from the same disease. 
Finally, a randomized trial is not an instru-
ment of discovery, but rather a means of 
validation. The significance tests applied to 
randomized trials ordinarily are concerned 
primarily with preventing erroneous rejection 
of a null hypothesis. Thus, they will reveal 
treatment differences at an error level of 5% 
only for very large deviations or with very 
large samples. Because of these limitations, 
Schneider remarked acidulously that "signifi-
cance tests are more adapted to preventing 
progress than to achieving it."s 
The last issue already evident in 1965 was 
allocation of resources. Who could forget the 
article in Life magazine more than 25 years 
ago in which a group of wise men in the state 
of Washington were shown deciding who of 
many supplicants with renal failure would be 
given the handful of positions for chronic 
hemodialysis available in the world. The same 
debates about allocation of scarce resources 
rage today, but with the focus on the limited 
organ supply or the cost per transplantation. 
Because I have never known how to divide 
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scarce resources, my approach has been 
always to try to eliminate the scarcity. Scarce 
transplantation resources have been expanded 
with increased cadaveric organ procurement 
through public education, and by devising 
procurement, preservation, and distribution 
techniques that have made more efficient use 
of the organ supply already available. Surely 
this is preferable to debating entry to candi-
dacy based on irrelevant criteria such as age, 
race, educational status, role in society, or 
national origin as has been advocated from 
time to time. It is possible that animal organs, 
possibly as distant from the human as the pig, 
will be found to be clinically valuable within 
the next few years by exploiting clues and 
knowledge about xenograft rejection that are 
already available. Then, the resource dividers 
will yield totally to the resource suppliers. 
Cost is the ultimate resource limitation 
either for the individual or for society. Until 
1973, renal transplantation could not be 
offered to any but the most wealthy recipients 
except on clinical research centers. This was 
changed in 1973 by the. federally mandated 
end-stage renal disease program. 
Although this was one of the most altruistic 
legislative initiatives ever taken, it was not 
free of complications. The cost quickly esca-
lated to the $2 billion-per-year level. A poten-
tial economic aristocracy was created 
amongst physicians and/or surgeons who con-
trolled "regional concessions" for dialysis, 
vascular access surgery, and transplantation. 
The struggles that have ensued for various 
franchises. within the End Stage Renal Dis-
ease (ESRD) Program, including cadaveric 
organ procurement agencies, sometimes have 
been ruthless. The competition between hospi-
tals for the economic and public relations 
advantages of transplant programs sometimes 
has had the appearance of corporate warfare. 
The pawns could easily be the patients who 
can be dehumanized by joining a captive 
population that has extremely limited options. 
Recipients on a cadaveric waiting list may feel 
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that they cannot be demanding, express their 
true feeling, or deviate in any way from docile 
behavior for fear of jeopardizing their candi-
dacy. I cannot tell you how many letters I have 
received from physicians or their assistants 
openly stating their ownership or proprietary 
relationships with their patients. It goes with-
out saying that we are the servants, not the 
masters, of our patients and the same goes for 
the nephrologists, hepatologists, and cardi-
ologists with whom we collaborate. Patients 
do not belong to doctors, to systems, or to 
hospitals. They belong to themselves. 
Recent legislation such as the so-called 
Gore bill of 1984, and amendments of 1986 
has mandated changes. During this spring and 
summer, great steps have been taken in the 
United States to ensure more fair, orderly, 
and efficient use of all the major organs. The 
task fell by federal contract to the transplant 
surgeons and physicians through their previ-
ously voluntary organization, the United Net-
work for Organ Sharing (UNOS). Everyone 
gave up some of their previously unchallenged 
independence in order to accommodate the 
common goal of serving the people. On Octo-
ber 1, 1987, the new system went into effect. 
There is a parallel data component through 
which a complete cross section of the national 
program can be developed. This permits reso-
lution of previously unanswered questions, 
and it will allow changes to be made systemat-
ically and intelligently in our future policies 
and practices. The timing of this international 
symposium on the eve of the new era is 
particularly significant. The location of the 
meeting in our city will be a source of pride to 
citizens of Pittsburgh for a long time. 
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THE SIMPLE PAST 
It is easier for me to talk about the past 
than to face the future. The work we did was 
once so simple. That has all changed. What 
was a crusade when it was not a reliable way 
of treatment became a business when it turned 
successful. The magical days were gone, not 
overnight but over a quarter of a century. This 
may have been just as well since victories 
easily won are lightly held. 
I do not really have a grand vision of what 
happened in the last 25 years, only details. I 
can see a thousand air strips rolled into one, 
days turned into nights, flashing lights, 
mournful sirens, pale faces drained of hope in 
donor hospitals, faces grown beautiful with 
restored vitality and visions of the future in 
the transplant centers. Someone once told me 
that the greatest gift of God was to see some-
thing of yourself, if only once, in the face of 
another human being. Those working in trans-
plantation have known this experience in the 
best of times and this experience has made 
bearable the worst of times. 
I have always been proud to be a surgeon. 
Sixty years ago, another surgeon wrote: "To 
give courage to those who need it, to restore 
the desire for life to those who have aban-
doned it, with our skill to heal disease or check 
its course, this is our great privilege. Ours are 
not the concerns of ordinary life. We who ... 
are doomed to go in company with pain and 
fear and bloodshed have a higher mission than 
other men, and it is for us to see that we are 
not unworthy.'" 
T.E. Starz! 
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